1. Home
  2. DCO vs MYGN Comparison

DCO vs MYGN Comparison

Compare DCO & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCO
  • MYGN
  • Stock Information
  • Founded
  • DCO 1849
  • MYGN 1991
  • Country
  • DCO United States
  • MYGN United States
  • Employees
  • DCO N/A
  • MYGN N/A
  • Industry
  • DCO Military/Government/Technical
  • MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • DCO Industrials
  • MYGN Health Care
  • Exchange
  • DCO Nasdaq
  • MYGN Nasdaq
  • Market Cap
  • DCO 1.0B
  • MYGN 1.2B
  • IPO Year
  • DCO N/A
  • MYGN 1995
  • Fundamental
  • Price
  • DCO $61.26
  • MYGN $14.18
  • Analyst Decision
  • DCO Strong Buy
  • MYGN Hold
  • Analyst Count
  • DCO 4
  • MYGN 13
  • Target Price
  • DCO $73.50
  • MYGN $22.54
  • AVG Volume (30 Days)
  • DCO 70.4K
  • MYGN 1.2M
  • Earning Date
  • DCO 02-27-2025
  • MYGN 02-24-2025
  • Dividend Yield
  • DCO N/A
  • MYGN N/A
  • EPS Growth
  • DCO 41.24
  • MYGN N/A
  • EPS
  • DCO 2.00
  • MYGN N/A
  • Revenue
  • DCO $781,490,000.00
  • MYGN $823,600,000.00
  • Revenue This Year
  • DCO $4.72
  • MYGN $13.60
  • Revenue Next Year
  • DCO $5.51
  • MYGN $3.25
  • P/E Ratio
  • DCO $31.29
  • MYGN N/A
  • Revenue Growth
  • DCO 3.78
  • MYGN 12.15
  • 52 Week Low
  • DCO $47.53
  • MYGN $12.04
  • 52 Week High
  • DCO $70.50
  • MYGN $29.30
  • Technical
  • Relative Strength Index (RSI)
  • DCO 29.54
  • MYGN 55.82
  • Support Level
  • DCO $61.95
  • MYGN $14.13
  • Resistance Level
  • DCO $63.27
  • MYGN $15.47
  • Average True Range (ATR)
  • DCO 1.73
  • MYGN 0.72
  • MACD
  • DCO -0.73
  • MYGN 0.27
  • Stochastic Oscillator
  • DCO 9.60
  • MYGN 61.38

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used primarily in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in worldwide technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

About MYGN Myriad Genetics Inc.

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.

Share on Social Networks: